BETAPRONE Drug Patent Profile
✉ Email this page to a colleague
When do Betaprone patents expire, and when can generic versions of Betaprone launch?
Betaprone is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in BETAPRONE is propiolactone. There is one drug master file entry for this compound. Additional details are available on the propiolactone profile page.
Summary for BETAPRONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Patent Applications: | 2,199 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BETAPRONE at DailyMed |
US Patents and Regulatory Information for BETAPRONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Labs | BETAPRONE | propiolactone | SOLUTION;IRRIGATION | 011657-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |